Compare Coursera Inc (COUR) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coursera Inc vs IDEXX Laboratories, Inc. — how do they compare? Coursera Inc trades at $5.16 (market cap $1.39B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 29.1× Coursera Inc's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 9,728,980). Which is the better fit depends on your goals — on Pluang, investors hold Coursera Inc for 47 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| COUR | IDXX | |
|---|---|---|
Market Cap | $1.39B | $40.43B |
Volume | 9,728,980 | 692,164 |
Sector | Consumer Staples | Health |
52-Week High | $10.73 | $766.68 |
52-Week Low | $4.64 | $504.70 |
Typical Hold Time | 47 Days | 46 Days |
Enterprise Value | $648.49M | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COUR trades at $5.27, up 3.13% today, with a mixed technical signal. Revenue growth is solid, reaching $757.5M in 2025, but the company remains unprofitable with a net loss of $51M. Analyst consensus is bullish with a $7.40 price target, and recent news highlights AI initiatives and institutional interest.
The stock offers upside based on analyst targets and revenue expansion, but persistent losses and integration risks from recent acquisitions pose challenges. Positive cash flow and a low EV/EBITDA of 0.04 provide valuation support, yet profitability remains the key hurdle for sustained gains.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
